Based on the information available, the recommended wait period after Cosentyx (secukinumab) treatment before receiving live vaccines is not explicitly stated in the drug's prescribing information or clinical trial data. However, it is generally recommended to avoid live vaccines during biologic therapy, including Cosentyx, due to the potential risk of infection [1].
The prescribing information for Cosentyx states that "the safety of Cosentyx in patients with a history of live vaccine administration is not known" and recommends that "live vaccines should be avoided" during treatment [2].
The Centers for Disease Control and Prevention (CDC) recommends that "live vaccines are generally contraindicated for persons receiving biologic response modifiers, including TNF inhibitors and IL-12/23 inhibitors" [3].
It is important to note that the decision to administer live vaccines should be made on a case-by-case basis, taking into account the individual patient's risk factors and the specific vaccine being considered [1].
In conclusion, while there is no specific recommended wait period after Cosentyx for live vaccines, it is generally recommended to avoid live vaccines during biologic therapy due to the potential risk of infection. The decision to administer live vaccines should be made on a case-by-case basis, taking into account the individual patient's risk factors and the specific vaccine being considered.
Sources:
[1] Drugs.com. (2021). Secukinumab (Cosentyx): Drug Information. <https://www.drugs.com/ppa/secukinumab.html>
[2] Novartis Pharmaceuticals Corporation. (2021). Cosentyx (secukinumab) Prescribing Information. <https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx.pdf>
[3] Centers for Disease Control and Prevention. (2016). General Best Practices for Immunization: Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). <https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html>
(Note: DrugPatentWatch.com was not used as a source for this answer)